These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30555697)

  • 21. Watson-Crick versus Hoogsteen Base Pairs: Chemical Strategy to Encode and Express Genetic Information in Life.
    Takahashi S; Sugimoto N
    Acc Chem Res; 2021 May; 54(9):2110-2120. PubMed ID: 33591181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electron transfer characteristics of 2'-deoxy-2'-fluoro-arabinonucleic acid, a nucleic acid with enhanced chemical stability.
    Teo RD; Terai K; Migliore A; Beratan DN
    Phys Chem Chem Phys; 2018 Nov; 20(41):26063-26067. PubMed ID: 30191207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
    Gait MJ; Agrawal S
    Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Materiomically Designed Polymeric Vehicles for Nucleic Acids: Quo Vadis?
    Kumar R
    ACS Appl Bio Mater; 2022 Jun; 5(6):2507-2535. PubMed ID: 35642794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleic Acid-Barcoding Technologies: Converting DNA Sequencing into a Broad-Spectrum Molecular Counter.
    Liszczak G; Muir TW
    Angew Chem Int Ed Engl; 2019 Mar; 58(13):4144-4162. PubMed ID: 30153374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications.
    Hamann A; Nguyen A; Pannier AK
    J Biol Eng; 2019; 13():7. PubMed ID: 30675180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of outcomes of amino acid modifications using a combinatorial approach to reveal physical and structural perturbations: A case study using trastuzumab biosimilar.
    Kamble R; Puranik A; Narvekar A; Dandekar P; Jain R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1209():123430. PubMed ID: 35988497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Xeno Nucleic Acids for Biomedical Application.
    Tu T; Huan S; Ke G; Zhang X
    Chem Res Chin Univ; 2022 Jul; ():1-7. PubMed ID: 35814030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
    Ashizawa AT; Cortes J
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational diversity versus nucleic acid triplex stability, a combinatorial study.
    Bernal-Méndez E; Leumann CJ
    J Biol Chem; 2001 Sep; 276(38):35320-7. PubMed ID: 11441024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleic Acids and Their Analogues for Biomedical Applications.
    Wang F; Li P; Chu HC; Lo PK
    Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical modification of nucleic acids as a key technology for the development of RNA-based therapeutics.
    Grünweller A; Hartmann RK
    Pharmazie; 2016 Jan; 71(1):8-16. PubMed ID: 26867347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides.
    Bege M; Borbás A
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes.
    Ni S; Yao H; Wang L; Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-Specific Tritium Labeling at the Predefined Internal Position of the Chemically-Modified RNA.
    Murase H; Lee J; Taniguchi Y; Sasaki S
    Chem Pharm Bull (Tokyo); 2023; 71(1):64-69. PubMed ID: 36596513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Structural Characterization of 2'-Deoxy-2'-fluoro-l-uridine Nucleic Acids.
    Dantsu Y; Zhang Y; Zhang W
    Org Lett; 2021 Jul; 23(13):5007-5011. PubMed ID: 34142829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2'-O-ribonucleic acid modifications.
    Egli M; Minasov G; Tereshko V; Pallan PS; Teplova M; Inamati GB; Lesnik EA; Owens SR; Ross BS; Prakash TP; Manoharan M
    Biochemistry; 2005 Jun; 44(25):9045-57. PubMed ID: 15966728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical Modifications of CRISPR RNAs to Improve Gene-Editing Activity and Specificity.
    Rozners E
    J Am Chem Soc; 2022 Jul; 144(28):12584-12594. PubMed ID: 35796760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA interference in mammalia cells by RNA-3'-PNA chimeras.
    Potenza N; Moggio L; Milano G; Salvatore V; Di Blasio B; Russo A; Messere A
    Int J Mol Sci; 2008 Mar; 9(3):299-315. PubMed ID: 19325750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
    Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
    J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.